Form 4 for MRVL Marvell Technology
Accepted 2022-04-19 00:00:00 ET · period of report 2022-04-15 · accession 0001209191-22-024881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-19 | 2022-04-15 | MRVL | Jarnac Dean E Jr. | EVP Worldwide Sales | M - OptEx | $0.00 | +13.4K | 57.6K | +30% | $0 |
| DM | 2022-04-19 | 2022-04-15 | MRVL | Jarnac Dean E Jr. | EVP Worldwide Sales | F - Tax | $60.97 | -6,658 | 56.8K | -10% | -$405.9K |
| DI | 2022-04-19 | 2022-04-19 | MRVL | Jarnac Dean E Jr. | EVP Worldwide Sales | S - Sale+OE | $60.96 | -6,000 | 24.9K | -19% | -$365.8K |
| DM | 2022-04-19 | 2022-04-15 | MRVL | Jarnac Dean E Jr. | EVP Worldwide Sales | M - OptEx | $0.00 | -13.4K | 11.1K | -55% | $0 |
| D | 2022-04-19 | 2022-04-15 | MRVL | Jarnac Dean E Jr. | EVP Worldwide Sales | A - Grant | $0.00 | +15.7K | 15.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-15 | M | A | 2,320 | $0.00 | 59,509 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-15 | F | D | 1,151 | $60.97 | 58,358 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-15 | M | A | 1,384 | $0.00 | 59,742 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-15 | F | D | 687 | $60.97 | 59,055 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-15 | F | D | 428 | $60.97 | 57,189 | D | — | — | |
| 6 | Common | Common Stock | 2022-04-15 | M | A | 8,858 | $0.00 | 61,147 | D By Trust | — | — | (F4) Shares are held in a revocable trust. Dean and Megan Jarnac are trustees of the trust, of which their children are the beneficiaries. |
| 7 | Common | Common Stock | 2022-04-15 | F | D | 4,392 | $60.97 | 56,755 | D | — | — | |
| 8 | Common | Common Stock | 2022-04-15 | M | A | 862 | $0.00 | 57,617 | D | — | — | |
| 9 | Common | Common Stock | 2022-04-19 | S | D | 6,000 | $60.96 | 24,879 | I | — | — | (F3) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| 10 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 2,320 | $0.00 | 9,279 | D | — · — to — | 2,320 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. (F7) The remaining RSU's will vest on 07/15/2022, 10/15/2022, 01/15/2023 and 04/15/2023. |
| 11 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 8,858 | $0.00 | 0 | D | — · — to — | 8,858 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. (F5) Grant is fully vested. |
| 12 | Derivative | Restricted Stock Units | 2022-04-15 | A | A | 15,746 | $0.00 | 15,746 | D | — · — to — | 15,746 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. (F8) The RSUs will vest in equal quarterly installments over three years, and were granted as part of the annual grant process. |
| 13 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 862 | $0.00 | 0 | D | — · — to — | 862 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. (F5) Grant is fully vested. |
| 14 | Derivative | Restricted Stock Units | 2022-04-15 | M | D | 1,384 | $0.00 | 11,071 | D | — · — to — | 1,384 Common Stock | (F2) Each RSU represents a contingent right to receive one Marvell Technology, Inc. common share upon vesting. (F6) The remaining RSUs vest quarterly on each of 04/15/2022, 07/15/2022, 10/15/2022, 01/15/2023, 04/15/2023, 07/15/2023, 10/15/2023, 01/15/2024 and 04/15/2024. |